GVOKE

Serial Number 98509233
688

Registration Progress

Application Filed
Apr 19, 2024
Under Examination
May 20, 2025
Approved for Publication
Dec 3, 2024
Published for Opposition
Dec 3, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Nov 20, 2025 128 days

Trademark Image

GVOKE

Basic Information

Serial Number
98509233
Filing Date
April 19, 2024
Published for Opposition
December 3, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
688
Status Date
May 20, 2025
Application
Pending
Classes
005

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
180 N LaSalle Street
Suite 1810
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
128 days remaining
NOA E-Mailed - SOU Required
Due Date
November 20, 2025
Extension Available
Until May 20, 2026

Application History

11 events
Date Code Type Description Documents
May 20, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2025 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Dec 16, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Dec 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 3, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 2, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 6, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 19, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases

Additional Information

Design Mark
The mark consists of two overlapping droplets positioned within a semi-circle, followed by the term "GVOKE".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005